SEC Form 4 · accession 0000914190-26-000129
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven C. Crouse
Officer — President - Diag & Spatial Bi
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 4:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 10,237 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF8,F15 | — | Aug 17, 2026 | A | 8,702 | A | — | — | Common Stock | 8,702 | 8,702 | D |
| Restricted Stock UnitsF8,F16 | — | Aug 17, 2026 | A | 14,140 | A | — | — | Common Stock | 14,140 | 14,140 | D |
| Stock Option (right to buy)F1 | $97.13 | holding | — | — | — | — | Apr 1, 2028 | Common Stock | 3,856 | 3,856 | D |
| Stock Option (right to buy)F1 | $120.46 | holding | — | — | — | — | Aug 6, 2028 | Common Stock | 19,032 | 19,032 | D |
| Stock Option (right to buy)F1 | $94.52 | holding | — | — | — | — | Aug 15, 2029 | Common Stock | 24,560 | 24,560 | D |
| Stock Option (right to buy)F2 | $84.61 | holding | — | — | — | — | Aug 15, 2030 | Common Stock | 12,649 | 12,649 | D |
| Stock Option (right to buy)F3 | $73.46 | holding | — | — | — | — | May 1, 2031 | Common Stock | 7,327 | 7,327 | D |
| Stock Option (right to buy)F4 | $74.91 | holding | — | — | — | — | Aug 15, 2034 | Common Stock | 17,133 | 17,133 | D |
| Stock Option (right to buy)F5 | $48.61 | holding | — | — | — | — | Jun 2, 2035 | Common Stock | 5,434 | 5,434 | D |
| Stock Option (right to buy)F6 | $53.60 | holding | — | — | — | — | Aug 15, 2035 | Common Stock | 19,151 | 19,151 | D |
| Stock Option (right to buy)F7 | $57.82 | holding | — | — | — | — | Mar 2, 2036 | Common Stock | 1,911 | 1,911 | D |
| Performance Restricted Stock UnitsF8,F9 | — | holding | — | — | — | — | — | Common Stock | 2,387 | 2,387 | D |
| Restricted Stock UnitsF8,F10 | — | holding | — | — | — | — | — | Common Stock | 794 | 794 | D |
| Restricted Stock UnitsF8,F11 | — | holding | — | — | — | — | — | Common Stock | 1,200 | 1,200 | D |
| Restricted Stock UnitsF8,F12 | — | holding | — | — | — | — | — | Common Stock | 1,869 | 1,869 | D |
| Restricted Stock UnitsF8,F13 | — | holding | — | — | — | — | — | Common Stock | 4,353 | 4,353 | D |
| Restricted Stock UnitsF8,F14 | — | holding | — | — | — | — | — | Common Stock | 735 | 735 | D |
Explanation of responses
- F1100% vested.
- F10794 restricted stock units vest on 5/1/2027.
- F11600 restricted stock units vest on each of 6/2/2027 and 6/2/2028.
- F121,869 restricted stock units vest on 8/15/2027.
- F132,177 restricted stock units vest on 8/15/2027, and 2,176 restricted stock units vest on 8/15/2028.
- F14245 restricted stock units vest on each of 3/2/2027, 3/2/2028 and 3/2/2029.
- F152,901 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 2,900 restricted stock units vest on 8/17/2029.
- F1614,140 restricted stock units vest on 8/17/2029.
- F2Options to purchase 3,162 shares vest on each of 8/15/2024, 8/15/2026 and 8/15/2027; and options to purchase 3,163 shares vest on 8/15/2025.
- F3Options to purchase 1,832 shares vest on each of 5/1/2025, 5/1/2026 and 5/1/2028; and options to purchase 1,831 shares vest on 5/1/2027.
- F4Options to purchase 4,283 shares vest on each of 8/15/2025, 8/15/2027 and 8/15/2028; and options to purchase 4,284 shares vest on 8/15/2026.
- F5Options to purchase 1,359 shares vest on each of 6/2/2026 and 6/2/2028; and options to purchase 1,358 shares vest on each of 6/2/2027 and 6/2/2029.
- F6Options to purchase 4,788 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2029; and options to purchase 4,787 shares vest on 8/15/2028.
- F7Options to purchase 478 shares vest on each of 3/2/2027, 3/2/2028 and 3/2/2030; and options to purchase 477 shares vest on 3/2/2029.
- F8Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F9Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).